HeartSciences Inc (HSCS) is not a good buy for a beginner, long-term investor at this time. The technical indicators are bearish, there is no significant positive news or catalysts, and the company's financial performance shows declining EPS and negative net income. Additionally, there are no strong trading signals or influential trades to support a buy decision.
The technical indicators are bearish. The MACD is below 0 and negatively contracting, the RSI is neutral at 43.208, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 2.789, with key support at 2.617 and resistance at 2.961.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Bearish technical indicators, declining EPS (-62.56% YoY), and negative net income (-$2,350,769).
In Q2 2026, revenue remained flat YoY at $2,419, while net income improved slightly by 12.86% YoY but remains negative. EPS dropped significantly by -62.56% YoY, and gross margin remained flat at 58.33%.
No analyst rating or price target data available.